Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 10/20 | 0.50 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.46 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.46 |
| ▸ | CETP | P11597 | 3/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.44 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3757478 | 0.91 | TBXAS1 (0.50) | TLR2PLA2G10PLA2G2ACETP | |
| SCHEMBL13058704 | 0.91 | TBXAS1 (0.50) | TLR2PLA2G10PLA2G2ACETP | |
| SCHEMBL26309045 | 0.87 | TLR2 (0.49) | TLR2PLA2G10PLA2G2A | |
| SCHEMBL25876430 | 0.86 | TLR2 (0.46) | TLR2PLA2G10PLA2G2ACETP | |
| SCHEMBL30396412 | 0.86 | TLR2 (0.49) | TLR2PLA2G10PLA2G2A | |
| SCHEMBL10519397 | 0.85 | TLR2 (0.45) | TLR2 | |
| SCHEMBL4748865 | 0.85 | CNR1 (0.53) | LPAR1LPAR3 | |
| SCHEMBL9575700 | 0.84 | TLR2 (0.44) | TLR2PLA2G10PLA2G2A | |
| SCHEMBL26305176 | 0.84 | TLR2 (0.47) | TLR2PLA2G10PLA2G2A | |
| SCHEMBL2411920 | 0.84 | PLA2G10 (0.55) | TLR2PLA2G10PLA2G2ACETPLPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025056467-A1 | POLYPHOSPHOESTER STABILIZING AGENTS, COMPOSITIONS, USES, AND MANUFACTURING METHODS THEREOF | GLOBAL LIFE SCIENCES SOLUTIONS CANADA ULC (CA) | 2025-03-20 | — | — | WO | disclosed |